The challenge of understanding cerebral white matter injury in the premature infant

Neuroscience

Volumn 276, Issue , 2014, Pages 216-238

  Elitt, C M ^a,b   Rosenberg, P A ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cerebral palsy; Glutamate; Nutrition; Oligodendrocyte; Prematurity; White matter

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; ESTROGEN; ICOSAPENTAENOIC ACID; LIOTHYRONINE; LONG CHAIN FATTY ACID; MYELIN; POLYUNSATURATED FATTY ACID; SOMATOMEDIN C; THYROXINE; VITAMIN K GROUP; ESTRADIOL; THYROID HORMONE;

BREAST MILK; CEREBRAL PALSY; CLINICAL LABORATORY; DISEASE COURSE; DISEASE MODEL; ENCEPHALOMALACIA; EXCITOTOXICITY; HUMAN; LIPID COMPOSITION; MALNUTRITION; MYELINATION; NEUROPATHOLOGY; NEWBORN INTENSIVE CARE; NONHUMAN; NUTRITION; NUTRITIONAL DEFICIENCY; OLIGODENDROGLIA; PREMATURITY; PRIORITY JOURNAL; REVIEW; WHITE MATTER INJURY; ANIMAL; BRAIN CORTEX; COMPLICATION; CONGENITAL MALFORMATION; ENCEPHALITIS; FEMALE; HISTORY; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INFANT, PREMATURE, DISEASES; LEUKOMALACIA, PERIVENTRICULAR; MATERNAL NUTRITION; MYELIN SHEATH; PATHOLOGY; PHYSIOLOGY; WHITE MATTER;

ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ENCEPHALITIS; ESTRADIOL; FEMALE; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INSULIN-LIKE GROWTH FACTOR I; LEUKOMALACIA, PERIVENTRICULAR; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MYELIN SHEATH; OLIGODENDROGLIA; THYROID HORMONES; WHITE MATTER;

EID: 84906791066     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.04.038     Document Type: Review

References (249)

1. AAP American Academy of Pediatrics Committee on Nutrition: Nutritional needs of low-birth-weight infants. Pediatrics 1985, 75:976-986.
2. Adams L.M., Emery J.R., Clark S.J., Carlton E.I., Nelson J.C. Reference ranges for newer thyroid function tests in premature infants. J Pediatr 1995, 126:122-127.
3. Adams-Chapman I., Bann C.M., Vaucher Y.E., Stoll B.J., Eunice Kennedy Shriver National Institute of Child Health, Human Development Neonatal Research Network Association between feeding difficulties and language delay in preterm infants using Bayley Scales of Infant Development-Third Edition. J Pediatr 2013, 163:680-685. e681-e683.
4. Aggarwal S., Yurlova L., Simons M. Central nervous system myelin: structure, synthesis and assembly. Trends Cell Biol 2011, 21:585-593.
5. Anderson P.J. Neuropsychological outcomes of children born very preterm. Semin Fetal Neonatal Med 2014, 19:90-96.
6. Anderson P.J., De Luca C.R., Hutchinson E., Spencer-Smith M.M., Roberts G., Doyle L.W., Victorian Infant Collaborative Study Group Attention problems in a representative sample of extremely preterm/extremely low birth weight children. Dev Neuropsychol 2011, 36:57-73.
7. Annunziata P., Federico A., D'Amore I., Corona R.M., Guazzi G.C. Impairment of human brain development: glycoconjugate and lipid changes in congenital athyroidism. Early Human Dev 1983, 8:269-278.
8. Arvanitis D.N., Wang H., Bagshaw R.D., Callahan J.W., Boggs J.M. Membrane-associated estrogen receptor and caveolin-1 are present in central nervous system myelin and oligodendrocyte plasma membranes. J Neurosci Res 2004, 75:603-613.
9. Aschheim S. Weitere Untersuchen uber Hormone und Schwangerschaft. Arch F Gynak 1927, 132:179-183.
10. Baas D., Fressinaud C., Ittel M.E., Reeber A., Dalencon D., Puymirat J., Sarlieve L.L. Expression of thyroid hormone receptor isoforms in rat oligodendrocyte cultures. Effect of 3,5,3'-triiodo-l-thyronine. Neurosci Lett 1994, 176:47-51.
11. Baas D., Bourbeau D., Sarlieve L.L., Ittel M.E., Dussault J.H., Puymirat J. Oligodendrocyte maturation and progenitor cell proliferation are independently regulated by thyroid hormone. Glia 1997, 19:324-332.
12. Baas D., Legrand C., Samarut J., Flamant F. Persistence of oligodendrocyte precursor cells and altered myelination in optic nerve associated to retina degeneration in mice devoid of all thyroid hormone receptors. Proc Natl Acad Sci USA 2002, 99:2907-2911.
13. Babcock D.S., Han B.K. The accuracy of high resolution, real-time ultrasonography of the head in infancy. Radiology 1981, 139:665-676.
14. Back SA, Rosenberg PA (2014) The roles of glia in perinatal white matter injury. Glia. [Epub ahead of print]. http://dx.doi.org/10.1002/glia.22658.
15. Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001, 21:1302-1312.
16. Back S.A., Riddle A., Dean J., Hohimer A.R. The instrumented fetal sheep as a model of cerebral white matter injury in the premature infant. Neurotherapeutics 2012, 9:359-370.
17. Banker B.Q., Larroche J.C. Periventricular leukomalacia of infancy. A form of neonatal anoxic encephalopathy. Arch Neurol 1962, 7:386-410.
18. Barnard D.E., Lewis S.M., Teter B.B., Thigpen J.E. Open- and closed-formula laboratory animal diets and their importance to research. J Am Assoc Lab Anim Sci: JAALAS 2009, 48:709-713.
19. Barres B.A., Lazar M.A., Raff M.C. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 1994, 120:1097-1108.
20. Bass N.H., Netsky M.G., Young E. Effect of neonatal malnutrition on developing cerebrum. II. Microchemical and histologic study of myelin formation in the rat. Arch Neurol 1970, 23:303-313.
21. Bass N.H., Netsky M.G., Young E. Effects of neonatal malnutrition on developing cerebrum. I. Microchemical and histologic study of cellular differentiation in the rat. Arch Neurol 1970, 23:289-302.
22. Batton B., Burnett C., Verhulst S., Batton D. Extremely preterm infant mortality rates and cesarean deliveries in the United States. Obstet Gynecol 2011, 118:43-48.
23. Beck K.D., Powell-Braxton L., Widmer H.R., Valverde J., Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995, 14:717-730.
24. Belfort M.B., Rifas-Shiman S.L., Kleinman K.P., Guthrie L.B., Bellinger D.C., Taveras E.M., Gillman M.W., Oken E. Infant feeding and childhood cognition at ages 3 and 7 years: effects of breastfeeding duration and exclusivity. JAMA Pediatr. 2013, 167:836-844.
25. Bennet L., Roelfsema V., George S., Dean J.M., Emerald B.S., Gunn A.J. The effect of cerebral hypothermia on white and grey matter injury induced by severe hypoxia in preterm fetal sheep. J Physiol 2007, 578:491-506.
26. Bennett A., Wilson D.M., Liu F., Nagashima R., Rosenfeld R.G., Hintz R.L. Levels of insulin-like growth factors I and II in human cord blood. J Clin Endocrinol Metab 1983, 57:609-612.
27. Benton J.W., Moser H.W., Dodge P.R., Carr S. Modification of the schedule of myelination in the rat by early nutritional deprivation. Pediatrics 1966, 38:801-807.
28. Berkow S.E., Campagnoni A.T. Essential fatty acid deficiency: effects of cross-fostering mice at birth on myelin levels and composition. J Nutr 1983, 113:582-591.
29. Berman D.R., Mozurkewich E., Liu Y., Barks J. Docosahexaenoic acid pretreatment confers neuroprotection in a rat model of perinatal cerebral hypoxia-ischemia. Am J Obstet Gynecol 2009, 200(305):e301-e306.
30. Berman D.R., Mozurkewich E., Liu Y., Shangguan Y., Barks J.D., Silverstein F.S. Docosahexaenoic acid augments hypothermic neuroprotection in a neonatal rat asphyxia model. Neonatology 2013, 104:71-78.
31. Bernard J.Y., De Agostini M., Forhan A., Alfaiate T., Bonet M., Champion V., Kaminski M., de Lauzon-Guillain B., Charles M.A., Heude B., Group EM-CCS Breastfeeding duration and cognitive development at 2 and 3 years of age in the EDEN mother-child cohort. J Pediatr 2013, 163:36-42. e31.
32. Billiards S.S., Haynes R.L., Folkerth R.D., Borenstein N.S., Trachtenberg F.L., Rowitch D.H., Ligon K.L., Volpe J.J., Kinney H.C. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathol 2008, 18:153-163.
33. Billon N., Jolicoeur C., Tokumoto Y., Vennstrom B., Raff M. Normal timing of oligodendrocyte development depends on thyroid hormone receptor alpha 1 (TRalpha1). EMBO J 2002, 21:6452-6460.
34. Birch E.E., Carlson S.E., Hoffman D.R., Fitzgerald-Gustafson K.M., Fu V.L., Drover J.R., Castaneda Y.S., Minns L., Wheaton D.K., Mundy D., Marunycz J., Diersen-Schade D.A. The DIAMOND (DHA Intake And Measurement Of Neural Development) Study: a double-masked, randomized controlled clinical trial of the maturation of infant visual acuity as a function of the dietary level of docosahexaenoic acid. Am J Clin Nutr 2010, 91:848-859.
35. Blackwell M.T., Eichenwald E.C., McAlmon K., Petit K., Linton P.T., McCormick M.C., Richardson D.K. Interneonatal intensive care unit variation in growth rates and feeding practices in healthy moderately premature infants. J Perinatol 2005, 25:478-485.
36. Blencowe H., Cousens S., Oestergaard M.Z., Chou D., Moller A.B., Narwal R., Adler A., Vera Garcia C., Rohde S., Say L., Lawn J.E. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012, 379:2162-2172.
37. Brambrink A.M., Back S.A., Riddle A., Gong X., Moravec M.D., Dissen G.A., Creeley C.E., Dikranian K.T., Olney J.W. Isoflurane-induced apoptosis of oligodendrocytes in the neonatal primate brain. Ann Neurol 2012, 72:525-535.
38. Buser J.R., Maire J., Riddle A., Gong X., Nguyen T., Nelson K., Luo N.L., Ren J., Struve J., Sherman L.S., Miller S.P., Chau V., Hendson G., Ballabh P., Grafe M.R., Back S.A. Arrested preoligodendrocyte maturation contributes to myelination failure in premature infants. Ann Neurol 2012, 71:93-109.
39. Cai Z., Fan L.W., Lin S., Pang Y., Rhodes P.G. Intranasal administration of insulin-like growth factor-1 protects against lipopolysaccharide-induced injury in the developing rat brain. Neuroscience 2011, 194:195-207.
40. Carre J.L., Demerens C., Rodriguez-Pena A., Floch H.H., Vincendon G., Sarlieve L.L. Thyroid hormone receptor isoforms are sequentially expressed in oligodendrocyte lineage cells during rat cerebral development. J Neurosci Res 1998, 54:584-594.
41. CDC (2013) U.S. Breastfeeding Rates Continue to Rise. http://www.cdc.gov/media/releases/2013/p0731-breastfeeding-rates.html.
42. Chase H.P. The effects of intrauterine and postnatal undernutrition on normal brain development. Ann NY Acad Sci 1973, 205:231-244.
43. Chase H.P., Dorsey J., McKhann G.M. The effect of malnutrition on the synthesis of a myelin lipid. Pediatrics 1967, 40:551-559.
44. Chowdhry P., Scanlon J.W., Auerbach R., Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics 1984, 73:301-305.
45. Clancy B., Kersh B., Hyde J., Darlington R.B., Anand K.J., Finlay B.L. Web-based method for translating neurodevelopment from laboratory species to humans. Neuroinformatics 2007, 5:79-94.
46. Clark R.H., Thomas P., Peabody J. Extrauterine growth restriction remains a serious problem in prematurely born neonates. Pediatrics 2003, 111:986-990.
47. Clarke P. Vitamin K prophylaxis for preterm infants. Early Human Dev 2010, 86(Suppl. 1):17-20.
48. Collaborative NECH Effects of neonatal screening for hypothyroidism: prevention of mental retardation by treatment before clinical manifestations. New England Congenital Hypothyroidism Collaborative. Lancet 1981, 2:1095-1098.
49. Conde C., Martinez M., Ballabriga A. Some chemical aspects of human brain development. I. Neutral glycosphingolipids, sulfatides, and sphingomyelin. Pediatr Res 1974, 8:89-92.
50. Cooke R. Postnatal growth in preterm infants: have we got it right?. J Perinatol 2005, 25(Suppl. 2):S12-S14.
51. Craig A., Ling Luo N., Beardsley D.J., Wingate-Pearse N., Walker D.W., Hohimer A.R., Back S.A. Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 2003, 181:231-240.
52. Creeley C., Dikranian K., Dissen G., Martin L., Olney J., Brambrink A. Propofol-induced apoptosis of neurones and oligodendrocytes in fetal and neonatal rhesus macaque brain. Br J Anaesth 2013, 110(Suppl. 1):i29-i38.
53. Crivello N.A., Casseus S.L., Peterson J.W., Smith D.E., Booth S.L. Age- and brain region-specific effects of dietary vitamin K on myelin sulfatides. J Nutr Biochem 2010, 21:1083-1088.
54. Cuzner M.L., Davison A.N., Gregson N.A. Chemical and metabolic studies of rat myelin of the central nervous system. Ann NY Acad Sci 1965, 122:86-94.
55. Davison A.N., Dobbing J. Myelination as a vulnerable period in brain development. Br Med Bull 1966, 22:40-44.
56. Davison A.N., Gregson N.A. The physiological role of cerebron sulphuric acid (sulphatide) in the brain. Biochem J 1962, 85:558-568.
57. Dean J.M., Moravec M.D., Grafe M., Abend N., Ren J., Gong X., Volpe J.J., Jensen F.E., Hohimer A.R., Back S.A. Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human. Dev Neurosci 2011, 33:251-260.
58. Dean J.M., van de Looij Y., Sizonenko S.V., Lodygensky G.A., Lazeyras F., Bolouri H., Kjellmer I., Huppi P.S., Hagberg H., Mallard C. Delayed cortical impairment following lipopolysaccharide exposure in preterm fetal sheep. Ann Neurol 2011, 70:846-856.
59. Deber C.M., Reynolds S.J. Central nervous system myelin: structure, function, and pathology. Clin Biochem 1991, 24:113-134.
60. Den Ouden A.L., Kok J.H., Verkerk P.H., Brand R., Verloove-Vanhorick S.P. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996, 39:142-145.
61. Deng W., Rosenberg P.A., Volpe J.J., Jensen F.E. Calcium-permeable AMPA/kainate receptors mediate toxicity and preconditioning by oxygen-glucose deprivation in oligodendrocyte precursors. Proc Natl Acad Sci USA 2003, 100:6801-6806.
62. Deoni S.C., Dean D.C., Piryatinsky I., O'Muircheartaigh J., Waskiewicz N., Lehman K., Han M., Dirks H. Breastfeeding and early white matter development: a cross-sectional study. NeuroImage 2013, 82C:77-86.
63. Derrick M., Luo N.L., Bregman J.C., Jilling T., Ji X., Fisher K., Gladson C.L., Beardsley D.J., Murdoch G., Back S.A., Tan S. Preterm fetal hypoxia-ischemia causes hypertonia and motor deficits in the neonatal rabbit: a model for human cerebral palsy?. J Neurosci 2004, 24:24-34.
64. Dobbing J. The entry of cholesterol into rat brain during development. J Neurochem 1963, 10:739-742.
65. Dobbing J. The influence of early nutrition on the development and myelination of the brain. Proc R Soc Lond Ser B 1964, 159:503-509.
66. Dobbing J., Sands J. Comparative aspects of the brain growth spurt. Early Hum Dev 1979, 3:79-83.
67. Dobbing J., Widdowson E.M. The effect of undernutrition and subsequent rehabilitation on myelination of rat brain as measured by its composition. Brain 1965, 88:357-366.
68. Donaldson H. The effect of underfeeding on the percentage of water, on the ether-alcohol extract, and on medullation in the central nervous system of the albino rat. J Comp Neurol 1911, 21:139-145.
69. Dubowitz L.M., Bydder G.M., Mushin J. Developmental sequence of periventricular leukomalacia. Correlation of ultrasound, clinical, and nuclear magnetic resonance functions. Arch Dis Child 1985, 60:349-355.
70. Dugas J.C., Emery B. Purification and culture of oligodendrocyte lineage cells. Cold Spring Harbor Protoc 2013, 2013:810-814.
71. Duncan J.R., Cock M.L., Scheerlinck J.P., Westcott K.T., McLean C., Harding R., Rees S.M. White matter injury after repeated endotoxin exposure in the preterm ovine fetus. Pediatr Res 2002, 52:941-949.
72. Edmond J. Essential polyunsaturated fatty acids and the barrier to the brain: the components of a model for transport. J Mol Neurosci 2001, 16:181-193. discussion 215-221.
73. Ehrenkranz R.A., Dusick A.M., Vohr B.R., Wright L.L., Wrage L.A., Poole W.K. Growth in the neonatal intensive care unit influences neurodevelopmental and growth outcomes of extremely low birth weight infants. Pediatrics 2006, 117:1253-1261.
74. Ehrenkranz R.A., Das A., Wrage L.A., Poindexter B.B., Higgins R.D., Stoll B.J., Oh W., Eunice Kennedy Shriver National Institute of Child Health, Human Development Neonatal Research Network Early nutrition mediates the influence of severity of illness on extremely LBW infants. Pediatr Res 2011, 69:522-529.
75. Elitt C.M., Sadowska G.B., Stopa E.G., Pinar H., Petersson K.H., Stonestreet B.S. Effects of antenatal steroids on ischemic brain injury in near-term ovine fetuses. Early Hum Dev 2003, 73:1-15.
76. Embleton N.E., Pang N., Cooke R.J. Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants?. Pediatrics 2001, 107:270-273.
77. Engle W.A., American Academy of Pediatrics Committee on Fetus and Newborn Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008, 121:419-432.
78. Fagel D.M., Ganat Y., Silbereis J., Ebbitt T., Stewart W., Zhang H., Ment L.R., Vaccarino F.M. Cortical neurogenesis enhanced by chronic perinatal hypoxia. Exp Neurol 2006, 199:77-91.
79. Fang A.Y., Gonzalez F.F., Sheldon R.A., Ferriero D.M. Effects of combination therapy using hypothermia and erythropoietin in a rat model of neonatal hypoxia-ischemia. Pediatr Res 2013, 73:12-17.
80. Fatemi A., Wilson M.A., Phillips A.W., McMahon M.T., Zhang J., Smith S.A., Arauz E.J., Falahati S., Gummadavelli A., Bodagala H., Mori S., Johnston M.V. In vivo magnetization transfer MRI shows dysmyelination in an ischemic mouse model of periventricular leukomalacia. J Cereb Blood Flow Metab 2011, 31:2009-2018.
81. Faulkner S., Bainbridge A., Kato T., Chandrasekaran M., Kapetanakis A.B., Hristova M., Liu M., Evans S., De Vita E., Kelen D., Sanders R.D., Edwards A.D., Maze M., Cady E.B., Raivich G., Robertson N.J. Xenon augmented hypothermia reduces early lactate/N-acetylaspartate and cell death in perinatal asphyxia. Ann Neurol 2011, 70:133-150.
82. Faulkner S.D., Downie N.A., Mercer C.J., Kerr S.A., Sanders R.D., Robertson N.J. A xenon recirculating ventilator for the newborn piglet: developing clinical applications of xenon for neonates. Eur J Anaesthesiol 2012, 29:577-585.
83. Feder H.H., Naftolin F., Ryan K.J. Male and female sexual responses in male rats given estradiol benzoate and 5 alpha-androstan-17 beta-ol-3-one propionate. Endocrinology 1974, 94:136-141.
84. Fern R., Moller T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J Neurosci 2000, 20:34-42.
85. Fewtrell M.S., Abbott R.A., Kennedy K., Singhal A., Morley R., Caine E., Jamieson C., Cockburn F., Lucas A. Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J Pediatr 2004, 144:471-479.
86. Fierro-Renoy J.F., Szuchet S., Falcone M., Macchia E., DeGroot L. Three different thyroid hormone receptor isoforms are detected in a pure culture of ovine oligodendrocytes. Glia 1995, 14:322-328.
87. Fishman M.A., Prensky A.L., Dodge P.R. Low content of cerebral lipids in infants suffering from malnutrition. Nature 1969, 221:552-553.
88. Follett P.L., Rosenberg P.A., Volpe J.J., Jensen F.E. NBQX attenuates excitotoxic injury in developing white matter. J Neurosci 2000, 20:9235-9241.
89. Follett P.L., Deng W., Dai W., Talos D.M., Massillon L.J., Rosenberg P.A., Volpe J.J., Jensen F.E. Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate. J Neurosci 2004, 24:4412-4420.
90. Fox J.H., Fishman M.A., Dodge P.R., Prensky A.L. The effect of malnutrition on human central nervous system myelin. Neurology 1972, 22:1213-1216.
91. Fraser M., Bennet L., Van Zijl P.L., Mocatta T.J., Williams C.E., Gluckman P.D., Winterbourn C.C., Gunn A.J. Extracellular amino acids and lipid peroxidation products in periventricular white matter during and after cerebral ischemia in preterm fetal sheep. J Neurochem 2008, 105:2214-2223.
92. Fuller G.N., Johnston D.A., Wiggins R.C. The relationship between nutritional adequacy and brain myelin accumulation: a comparison of varying degrees of well fed and undernourished rats. Brain Res 1984, 290:195-198.
93. Fumagalli R., Smith M.E., Urna G., Paoletti R. The effect of hypocholesteremic agents on myelinogenesis. J Neurochem 1969, 16:1329-1339.
94. Fuse Y., Shimizu M., Uga N., Fujii T., Irie M. Maturation of feedback control of thyrotropin in premature infants. J Dev Physiol 1990, 14:17-22.
95. Galler J.R., Ramsey F., Solimano G., Kucharski L.T., Harrison R. The influence of early malnutrition on subsequent behavioral development. IV. Soft neurologic signs. Pediatr Res 1984, 18:826-832.
96. Galler J.R., Ramsey F.C., Morley D.S., Archer E., Salt P. The long-term effects of early kwashiorkor compared with marasmus. IV. Performance on the national high school entrance examination. Pediatr Res 1990, 28:235-239.
97. Galli C., White H.B., Paoletti R. Brain lipid modifications induced by essential fatty acid deficiency in growing male and female rats. J Neurochem 1970, 17:347-355.
98. Gard A.L., Pfeiffer S.E. Oligodendrocyte progenitors isolated directly from developing telencephalon at a specific phenotypic stage: myelinogenic potential in a defined environment. Development 1989, 106:119-132.
99. Gard A.L., Pfeiffer S.E. Glial cell mitogens bFGF and PDGF differentially regulate development of O4+GalC- oligodendrocyte progenitors. Dev Biol 1993, 159:618-630.
100. Gerstner B., Sifringer M., Dzietko M., Schuller A., Lee J., Simons S., Obladen M., Volpe J.J., Rosenberg P.A., Felderhoff-Mueser U. Estradiol attenuates hyperoxia-induced cell death in the developing white matter. Ann Neurol 2007, 61:562-573.
101. Gerstner B., DeSilva T.M., Genz K., Armstrong A., Brehmer F., Neve R.L., Felderhoff-Mueser U., Volpe J.J., Rosenberg P.A. Hyperoxia causes maturation-dependent cell death in the developing white matter. J Neurosci 2008, 28:1236-1245.
102. Gerstner B., Lee J., DeSilva T.M., Jensen F.E., Volpe J.J., Rosenberg P.A. 17beta-estradiol protects against hypoxic/ischemic white matter damage in the neonatal rat brain. J Neurosci Res 2009, 87:2078-2086.
103. Goldenberg R.L., Culhane J.F., Iams J.D., Romero R. Epidemiology and causes of preterm birth. Lancet 2008, 371:75-84.
104. Graham E.M., Sheldon R.A., Flock D.L., Ferriero D.M., Martin L.J., O'Riordan D.P., Northington F.J. Neonatal mice lacking functional Fas death receptors are resistant to hypoxic-ischemic brain injury. Neurobiol Dis 2004, 17:89-98.
105. Griffith J.L., Shimony J.S., Cousins S.A., Rees S.E., McCurnin D.C., Inder T.E., Neil J.J. MR imaging correlates of white-matter pathology in a preterm baboon model. Pediatr Res 2012, 71:185-191.
106. Guan J., Bennet L., George S., Wu D., Waldvogel H.J., Gluckman P.D., Faull R.L., Crosier P.S., Gunn A.J. Insulin-like growth factor-1 reduces postischemic white matter injury in fetal sheep. J Cereb Blood Flow Metab 2001, 21:493-502.
107. Hack M., Taylor H.G., Drotar D., Schluchter M., Cartar L., Andreias L., Wilson-Costello D., Klein N. Chronic conditions, functional limitations, and special health care needs of school-aged children born with extremely low-birth-weight in the 1990s. JAMA 2005, 294:318-325.
108. Halliday H.L. Surfactants: past, present and future. J Perinatol 2008, 28(Suppl. 1):S47-S56.
109. Hansen-Pupp I., Hellstrom-Westas L., Cilio C.M., Andersson S., Fellman V., Ley D. Inflammation at birth and the insulin-like growth factor system in very preterm infants. Acta Paediatr 2007, 96:830-836.
110. Hansen-Pupp I., Hovel H., Hellstrom A., Hellstrom-Westas L., Lofqvist C., Larsson E.M., Lazeyras F., Fellman V., Huppi P.S., Ley D. Postnatal decrease in circulating insulin-like growth factor-I and low brain volumes in very preterm infants. J Clin Endocrinol Metab 2011, 96:1129-1135.
111. Hansen-Pupp I., Lofqvist C., Polberger S., Niklasson A., Fellman V., Hellstrom A., Ley D. Influence of insulin-like growth factor I and nutrition during phases of postnatal growth in very preterm infants. Pediatr Res 2011, 69:448-453.
112. Hansen-Pupp I., Hovel H., Lofqvist C., Hellstrom-Westas L., Fellman V., Huppi P.S., Hellstrom A. Ley D Circulatory insulin-like growth factor-I and brain volumes in relation to neurodevelopmental outcome in very preterm infants. Pediatr Res 2013, 74:564-569.
113. Hazell A.S., Butterworth R.F. Update of cell damage mechanisms in thiamine deficiency: focus on oxidative stress, excitotoxicity and inflammation. Alcohol Alcohol 2009, 44:141-147.
114. Honeycutt A., Dunlap L., Chen H., Al Homsi G. Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment-United States, 2003. MMWR 2004, 53:57-59.
115. Hung P.L., Huang C.C., Huang H.M., Tu D.G., Chang Y.C. Thyroxin treatment protects against white matter injury in the immature brain via brain-derived neurotrophic factor. Stroke 2013, 44:2275-2283.
116. Huppi P.S., Warfield S., Kikinis R., Barnes P.D., Zientara G.P., Jolesz F.A., Tsuji M.K., Volpe J.J. Quantitative magnetic resonance imaging of brain development in premature and mature newborns. Ann Neurol 1998, 43:224-235.
117. Hwang Y.S., Ma M.C., Tseng Y.M. Tsai WH Associations among perinatal factors and age of achievement of full oral feeding in very preterm infants. Pediatr Neonatol 2013, 54:309-314.
118. Inder T.E., Anderson N.J., Spencer C., Wells S., Volpe J.J. White matter injury in the premature infant: a comparison between serial cranial sonographic and MR findings at term. AJNR Am J Neuroradiol 2003, 24:805-809.
119. Inder T.E., Wells S.J., Mogridge N.B., Spencer C., Volpe J.J. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J Pediatr 2003, 143:171-179.
120. Inder T., Neil J., Yoder B., Rees S. Patterns of cerebral injury in a primate model of preterm birth and neonatal intensive care. J Child Neurol 2005, 20:965-967.
121. Isaacs E.B., Fischl B.R., Quinn B.T., Chong W.K., Gadian D.G., Lucas A. Impact of breast milk on intelligence quotient, brain size, and white matter development. Pediatr Res 2010, 67:357-362.
122. Ishida T., Seo F., Hirato K., Fukuda T., Yanaihara T., Araki H., Nakayama T. Changes in placental enzymatic activities in relation to estrogen production during pregnancy. Nihon Sanka Fujinka Gakkai zasshi 1985, 37:547-554.
123. Itoh T., Beesley J., Itoh A., Cohen A.S., Kavanaugh B., Coulter D.A., Grinspan J.B., Pleasure D. AMPA glutamate receptor-mediated calcium signaling is transiently enhanced during development of oligodendrocytes. J Neurochem 2002, 81:390-402.
124. Jacques C., Levy E., Muckle G., Jacobson S.W., Bastien C., Dewailly E., Ayotte P., Jacobson J.L., Saint-Amour D. Long-term effects of prenatal omega-3 fatty acid intake on visual function in school-age children. J Pediatr 2011, 158:83-90. 90.e81.
125. Jantzie LL, Talos DM, Jackson MC, Park HK, Graham DA, Lechpammer M, Folkerth RD, Volpe JJ, Jensen FE (2013) Developmental expression of N-methyl-d-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain. Cereb Cortex. [Epub ahead of print].
126. Jhala S.S., Hazell A.S. Modeling neurodegenerative disease pathophysiology in thiamine deficiency: consequences of impaired oxidative metabolism. Neurochem Int 2011, 58:248-260.
127. Jung-Testas I., Renoir M., Bugnard H., Greene G.L., Baulieu E.E. Demonstration of steroid hormone receptors and steroid action in primary cultures of rat glial cells. J Steroid Biochem Mol Biol 1992, 41:621-631.
128. Jurevics H., Morell P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J Neurochem 1995, 64:895-901.
129. Karadottir R., Cavelier P., Bergersen L.H., Attwell D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 2005, 438:1162-1166.
130. Kerenyi A., Kelen D., Faulkner S.D., Bainbridge A., Chandrasekaran M., Cady E.B., Golay X., Robertson N.J. Systemic effects of whole-body cooling to 35°C, 33.5°C, and 30°C in a piglet model of perinatal asphyxia: implications for therapeutic hypothermia. Pediatr Res 2012, 71:573-582.
131. Kinney H.C., Volpe J.J. Modeling the encephalopathy of prematurity in animals: the important role of translational research. Neurol Res Int 2012, 2012:295389.
132. Kinney H.C., Brody B.A., Kloman A.S., Gilles F.H. Sequence of central nervous system myelination in human infancy. II. Patterns of myelination in autopsied infants. J Neuropathol Exp Neurol 1988, 47:217-234.
133. Kinney H.C., Karthigasan J., Borenshteyn N.I., Flax J.D., Kirschner D.A. Myelination in the developing human brain: biochemical correlates. Neurochem Res 1994, 19:983-996.
134. Klein A.H., Meltzer S., Kenny F.M. Improved prognosis in congenital hypothyroidism treated before age three months. J Pediatr 1972, 81:912-915.
135. Klein A.H., Agustin A.V., Foley T.P. Successful laboratory screening for congenital hypothyroidism. Lancet 1974, 2:77-79.
136. Krigman M.R., Hogan E.L. Undernutrition in the developing rat: effect upon myelination. Brain Res 1976, 107:239-255.
137. Kumar D., Greer F.R., Super D.M., Suttie J.W., Moore J.J. Vitamin K status of premature infants: implications for current recommendations. Pediatrics 2001, 108:1117-1122.
138. La Gamma E.F., Paneth N. Clinical importance of hypothyroxinemia in the preterm infant and a discussion of treatment concerns. Curr Opin Pediatr 2012, 24:172-180.
139. La Gamma E.F., van Wassenaer A.G., Ares S., Golombek S.G., Kok J.H., Quero J., Hong T., Rahbar M.H., de Escobar G.M., Fisher D.A., Paneth N. Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation. Pediatrics 2009, 124:e258-e268.
140. Lafeber H.N., van de Lagemaat M., Rotteveel J., van Weissenbruch M. Timing of nutritional interventions in very-low-birth-weight infants: optimal neurodevelopment compared with the onset of the metabolic syndrome. Am J Clin Nutr 2013, 98:556S-560S.
141. Langford K., Nicolaides K., Miell J.P. Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy. Hum Reprod 1998, 13:1389-1393.
142. Langlais P.J., Mair R.G. Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci 1990, 10:1664-1674.
143. Langlais P.J., Zhang S.X. Extracellular glutamate is increased in thalamus during thiamine deficiency-induced lesions and is blocked by MK-801. J Neurochem 1993, 61:2175-2182.
144. Lapillonne A., Griffin I.J. Feeding preterm infants today for later metabolic and cardiovascular outcomes. J Pediatr 2013, 162:S7-S16.
145. Lapillonne A., Eleni dit Trolli S., Kermorvant-Duchemin E. Postnatal docosahexaenoic acid deficiency is an inevitable consequence of current recommendations and practice in preterm infants. Neonatology 2010, 98:397-403.
146. Lapillonne A., Groh-Wargo S., Gonzalez C.H., Uauy R. Lipid needs of preterm infants: updated recommendations. J Pediatr 2013, 162:S37-S47.
147. Lassarre C., Hardouin S., Daffos F., Forestier F., Frankenne F., Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991, 29:219-225.
148. Latal-Hajnal B., von Siebenthal K., Kovari H., Bucher H.U., Largo R.H. Postnatal growth in VLBW infants: significant association with neurodevelopmental outcome. J Pediatr 2003, 143:163-170.
149. Lemons J.A., Bauer C.R., Oh W., Korones S.B., Papile L.A., Stoll B.J., Verter J., Temprosa M., Wright L.L., Ehrenkranz R.A., Fanaroff A.A., Stark A., Carlo W., Tyson J.E., Donovan E.F., Shankaran S., Stevenson D.K. Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995-December 1996. NICHD Neonatal Research Network. Pediatrics 2001, 107:E1.
150. Leviton A., Gilles F.H. An epidemiologic study of perinatal telencephalic leucoencephalopathy in an autopsy population. J Neurol Sci 1973, 18:53-66.
151. Leviton A., Paneth N., Reuss M.L., Susser M., Allred E.N., Dammann O., Kuban K., Van Marter L.J., Pagano M. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage. J Pediatr 1999, 134:706-711.
152. Ley D., Hansen-Pupp I., Niklasson A., Domellof M., Friberg L.E., Borg J., Lofqvist C., Hellgren G., Smith L.E., Hard A.L., Hellstrom A. Longitudinal infusion of a complex of insulin-like growth factor-I and IGF-binding protein-3 in five preterm infants: pharmacokinetics and short-term safety. Pediatr Res 2013, 73:68-74.
153. Li J., Lin J.C., Wang H., Peterson J.W., Furie B.C., Furie B., Booth S.L., Volpe J.J., Rosenberg P.A. Novel role of vitamin K in preventing oxidative injury to developing oligodendrocytes and neurons. J Neurosci 2003, 23:5816-5826.
154. Lineham J.D., Smith R.M., Dahlenburg G.W., King R.A., Haslam R.R., Stuart M.C., Faull L. Circulating insulin-like growth factor I levels in newborn premature and full-term infants followed longitudinally. Early Human Dev 1986, 13:37-46.
155. Liu J., Sheldon R.A., Segal M., Kelly M.J., Pelton J.G., Ferriero D.M., James T.L., Litt L. H nuclear magnetic resonance (NMR) brain metabolomics in neonatal mice after hypoxia-ischemia distinguished normothermic recovery from mild hypothermia recoveries. Pediatr Res 2013, 74:170-179.
156. Lucas A., Rennie J., Baker B.A., Morley R. Low plasma triiodothyronine concentrations and outcome in preterm infants. Arch Dis Child 1988, 63:1201-1206.
157. Lucas A., Morley R., Cole T.J., Lister G., Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm. Lancet 1992, 339:261-264.
158. Maalouf E.F., Duggan P.J., Counsell S.J., Rutherford M.A., Cowan F., Azzopardi D., Edwards A.D. Comparison of findings on cranial ultrasound and magnetic resonance imaging in preterm infants. Pediatrics 2001, 107:719-727.
159. Mallard C., Welin A.K., Peebles D., Hagberg H., Kjellmer I. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem Res 2003, 28:215-223.
160. Manning S.M., Talos D.M., Zhou C., Selip D.B., Park H.K., Park C.J., Volpe J.J., Jensen F.E. NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. J Neurosci 2008, 28:6670-6678.
161. Martin B., Ji S., Maudsley S., Mattson M.P. "Control" laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci USA 2010, 107:6127-6133.
162. Martinez M. Myelin lipids in the developing cerebrum, cerebellum, and brain stem of normal and undernourished children. J Neurochem 1982, 39:1684-1692.
163. Martinez M., Ballabriga A. A chemical study on the development of the human forebrain and cerebellum during the brain 'growth spurt' period. I. Gangliosides and plasmalogens. Brain Res 1978, 159:351-362.
164. Martinez M., Conde C., Ballabriga A. Some chemical aspects of human brain development. II. Phosphoglyceride fatty acids. Pediatr Res 1974, 8:93-102.
165. McCarthy M.M. Estradiol and the developing brain. Physiol Rev 2008, 88:91-124.
166. McEwen B.S., Lieberburg I., Chaptal C., Krey L.C. Aromatization: important for sexual differentiation of the neonatal rat brain. Horm Behav 1977, 9:249-263.
167. McKenna M.C., Campagnoni A.T. Effect of pre- and postnatal essential fatty acid deficiency on brain development and myelination. J Nutr 1979, 109:1195-1204.
168. Ment L.R., Schwartz M., Makuch R.W., Stewart W.B. Association of chronic sublethal hypoxia with ventriculomegaly in the developing rat brain. Brain Res Dev Brain Res 1998, 111:197-203.
169. Mercier C.E., Dunn M.S., Ferrelli K.R., Howard D.B., Soll R.F., Vermont Oxford Network EIF-USG Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford network: 1998-2003. Neonatology 2010, 97:329-338.
170. Miller S.P., Ferriero D.M., Leonard C., Piecuch R., Glidden D.V., Partridge J.C., Perez M., Mukherjee P., Vigneron D.B., Barkovich A.J. Early brain injury in premature newborns detected with magnetic resonance imaging is associated with adverse early neurodevelopmental outcome. J Pediatr 2005, 147:609-616.
171. Moncrieff A. The value of oestrin for premature babies. Arch Dis Child 1936, 11:9-20.
172. Mortensen E.L., Michaelsen K.F., Sanders S.A., Reinisch J.M. The association between duration of breastfeeding and adult intelligence. JAMA 2002, 287:2365-2371.
173. Nakhasi H.L., Toews A.D., Horrocks L.A. Effects of a postnatal protein deficiency on the content and composition of myelin from brains of weanling rats. Brain Res 1975, 83:176-179.
174. Nelson K.B., Dambrosia J.M., Grether J.K., Phillips T.M. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998, 44:665-675.
175. Ness J.K., Wood T.L. Insulin-like growth factor I, but not neurotrophin-3, sustains Akt activation and provides long-term protection of immature oligodendrocytes from glutamate-mediated apoptosis. Mol Cell Neurosci 2002, 20:476-488.
176. Ness J.K., Scaduto R.C., Wood T.L. IGF-I prevents glutamate-mediated bax translocation and cytochrome C release in O4+ oligodendrocyte progenitors. Glia 2004, 46:183-194.
177. Noguchi T., Sugisaki T., Satoh I., Kudo M. Partial restoration of cerebral myelination of the congenitally hypothyroid mouse by parenteral or breast milk administration of thyroxine. J Neurochem 1985, 45:1419-1426.
178. O'Brien J.S., Sampson E.L. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J Lipid Res 1965, 6:537-544.
179. Osborn DA, Hunt RW (2007) Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database Syst Rev CD005945.
180. O'Shea T.M., Shah B., Allred E.N., Fichorova R.N., Kuban K.C., Dammann O., Leviton A., Investigators ELGAN Study Inflammation-initiating illnesses, inflammation-related proteins, and cognitive impairment in extremely preterm infants. Brain Behav Immun 2013, 29:104-112.
181. Oshida K., Shimizu T., Takase M., Tamura Y., Shimizu T., Yamashiro Y. Effects of dietary sphingomyelin on central nervous system myelination in developing rats. Pediatr Res 2003, 53:589-593.
182. Pacagnella P.A., Parpinelli P.M., Lachat J.J. The morphological and developmental changes of the anterior commissure of male Wistar rats submitted to protein malnutrition in the postnatal period. Nutr Neurosci 2013, 16:61-68.
183. Parker M.G., Barrero-Castillero A., Corwin B.K., Kavanagh P.L., Belfort M.B., Wang C.J. Pasteurized human donor milk use among US level 3 neonatal intensive care units. J Hum Lact 2013, 29:381-389.
184. Prayer D., Roberts T., Barkovich A.J., Prayer L., Kucharczyk J., Moseley M., Arieff A. Diffusion-weighted MRI of myelination in the rat brain following treatment with gonadal hormones. Neuroradiology 1997, 39:320-325.
185. Preston M., Gong X., Su W., Matsumoto S.G., Banine F., Winkler C., Foster S., Xing R., Struve J., Dean J., Baggenstoss B., Weigel P.H., Montine T.J., Back S.A., Sherman L.S. Digestion products of the PH20 hyaluronidase inhibit remyelination. Ann Neurol 2013, 73:266-280.
186. Rasch S., Sangild P.T., Gregersen H., Schmidt M., Omari T., Lau C. The preterm piglet - a model in the study of oesophageal development in preterm neonates. Acta Paediatr 2010, 99:201-208.
187. Reuss M.L., Paneth N., Pinto-Martin J.A., Lorenz J.M., Susser M. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996, 334:821-827.
188. Reuss M.L., Leviton A., Paneth N., Susser M. Thyroxine values from newborn screening of 919 infants born before 29 weeks' gestation. Am J Public Health 1997, 87:1693-1697.
189. Ritter J., Schmitz T., Chew L.J., Buhrer C., Mobius W., Zonouzi M., Gallo V. Neonatal hyperoxia exposure disrupts axon-oligodendrocyte integrity in the subcortical white matter. J Neurosci 2013, 33:8990-9002.
190. Robain O., Ponsot G. Effects of undernutrition on glial maturation. Brain Res 1978, 149:379-397.
191. Robertson N.J., Faulkner S., Fleiss B., Bainbridge A., Andorka C., Price D., Powell E., Lecky-Thompson L., Thei L., Chandrasekaran M., Hristova M., Cady E.B., Gressens P., Golay X., Raivich G. Melatonin augments hypothermic neuroprotection in a perinatal asphyxia model. Brain 2013, 136:90-105.
192. Rosenberg P.A. Mechanisms underlying the selective vulnerability of developing human white matter. White matter injury in stroke and CNS disease. Springer Series in Translational Stroke Research 2014, Springer Science and Business Media. S. Baltan (Ed.).
193. Rosenberg P.A., Dai W., Gan X.D., Ali S., Fu J., Back S.A., Sanchez R.M., Segal M.M., Follett P.L., Jensen F.E., Volpe J.J. Mature myelin basic protein-expressing oligodendrocytes are insensitive to kainate toxicity. J Neurosci Res 2003, 71:237-245.
194. Rosman N.P. The neuropathology of congenital hypothyroidism. Adv Exp Med Biol 1972, 30:337-366.
195. Rosman N.P., Malone M.J., Helfenstein M., Kraft E. The effect of thyroid deficiency on myelination of brain. A morphological and biochemical study. Neurology 1972, 22:99-106.
196. Royland J., Klinkhachorn P., Konat G., Wiggins R.C. How much undernourishment is required to retard brain myelin development. Neurochem Int 1992, 21:269-274.
197. Saher G., Brugger B., Lappe-Siefke C., Mobius W., Tozawa R., Wehr M.C., Wieland F., Ishibashi S., Nave K.A. High cholesterol level is essential for myelin membrane growth. Nat Neurosci 2005, 8:468-475.
198. Saher G., Rudolphi F., Corthals K., Ruhwedel T., Schmidt K.F., Lowel S., Dibaj P., Barrette B., Mobius W., Nave K.A. Therapy of Pelizaeus-Merzbacher disease in mice by feeding a cholesterol-enriched diet. Nat Med 2012, 18:1130-1135.
199. Salter M.G., Fern R. NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 2005, 438:1167-1171.
200. Salvati S., Sanchez M., Campeggi L.M., Suchanek G., Breitschop H., Lassmann H. Accelerated myelinogenesis by dietary lipids in rat brain. J Neurochem 1996, 67:1744-1750.
201. Sanchez-Gomez M.V., Alberdi E., Perez-Navarro E., Alberch J., Matute C. Bax and calpain mediate excitotoxic oligodendrocyte death induced by activation of both AMPA and kainate receptors. J Neurosci 2011, 31:2996-3006.
202. Sangild P.T., Thymann T., Schmidt M., Stoll B., Burrin D.G., Buddington R.K. Invited review: the preterm pig as a model in pediatric gastroenterology. J Anim Sci 2013, 91:4713-4729.
203. Schulzke SM, Patole SK, Simmer K (2011) Long-chain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev CD000375.
204. Segovia K.N., McClure M., Moravec M., Luo N.L., Wan Y., Gong X., Riddle A., Craig A., Struve J., Sherman L.S., Back S.A. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Ann Neurol 2008, 63:520-530.
205. Selip D.B., Jantzie L.L., Chang M., Jackson M.C., Fitzgerald E.C., Boll G., Murphy A., Jensen F.E. Regional differences in susceptibility to hypoxic-ischemic injury in the preterm brain: exploring the spectrum from white matter loss to selective grey matter injury in a rat model. Neurol Res Int 2012, 2012:725184.
206. Semple B.D., Blomgren K., Gimlin K., Ferriero D.M., Noble-Haeusslein L.J. Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol 2013, 106-107:1-16.
207. Senterre T., Rigo J. Optimizing early nutritional support based on recent recommendations in VLBW infants and postnatal growth restriction. J Pediatr Gastroenterol Nutr 2011, 53:536-542.
208. Shah D.K., Doyle L.W., Anderson P.J., Bear M., Daley A.J., Hunt R.W., Inder T.E. Adverse neurodevelopment in preterm infants with postnatal sepsis or necrotizing enterocolitis is mediated by white matter abnormalities on magnetic resonance imaging at term. J Pediatr 2008, 153:170-175. 175.e171.
209. Sheldon R.A., Aminoff A., Lee C.L., Christen S., Ferriero D.M. Hypoxic preconditioning reverses protection after neonatal hypoxia-ischemia in glutathione peroxidase transgenic murine brain. Pediatr Res 2007, 61:666-670.
210. Sikes R.W., Fuller G.N., Colbert C., Chronister R.B., DeFrance J., Wiggins R.C. The relative numbers of oligodendroglia in different brain regions of normal and postnatally undernourished rats. Brain Res Bull 1981, 6:385-391.
211. Smithers L.G., Collins C.T., Simmonds L.A., Gibson R.A., McPhee A., Makrides M. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial. Am J Clin Nutr 2010, 91:628-634.
212. Stephens B.E., Walden R.V., Gargus R.A., Tucker R., McKinley L., Mance M., Nye J., Vohr B.R. First-week protein and energy intakes are associated with 18-month developmental outcomes in extremely low birth weight infants. Pediatrics 2009, 123:1337-1343.
213. Stoll B.J., Hansen N.I., Adams-Chapman I., Fanaroff A.A., Hintz S.R., Vohr B., Higgins R.D., National Institute of Child Health, Human Development Neonatal Research Network Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004, 292:2357-2365.
214. Sugita N. Comparative studies on the growth of the cerebral cortex. J Comp Neurol 1918, 29:177-239.
215. Sundaram K.S., Fan J.H., Engelke J.A., Foley A.L., Suttie J.W., Lev M. Vitamin K status influences brain sulfatide metabolism in young mice and rats. J Nutr 1996, 126:2746-2751.
216. Talos D.M., Fishman R.E., Park H., Folkerth R.D., Follett P.L., Volpe J.J., Jensen F.E. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex. J Comp Neurol 2006, 497:42-60.
217. Talos D.M., Follett P.L., Folkerth R.D., Fishman R.E., Trachtenberg F.L., Volpe J.J., Jensen F.E. Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex. J Comp Neurol 2006, 497:61-77.
218. Trotter A., Maier L., Grill H.J., Wudy S.A., Pohlandt F. 17Beta-estradiol and progesterone supplementation in extremely low-birth-weight infants. Pediatr Res 1999, 45:489-493.
219. Trotter A., Maier L., Pohlandt F. Management of the extremely preterm infant: is the replacement of estradiol and progesterone beneficial?. Paediatr Drugs 2001, 3:629-637.
220. Trotter A., Steinmacher J., Kron M., Pohlandt F. Neurodevelopmental follow-up at five years corrected age of extremely low birth weight infants after postnatal replacement of 17beta-estradiol and progesterone. J Clin Endocrinol Metab 2012, 97:1041-1047.
221. Tulchinsky D., Hobel C.J., Yeager E., Marshall J.R. Plasma estrone, estradiol, estriol, progesterone, and 17-hydroxyprogesterone in human pregnancy. I. Normal pregnancy. Am J Obstet Gynecol 1972, 112:1095-1100.
222. Tuzun F., Kumral A., Dilek M., Ozbal S., Ergur B., Yesilirmak D.C., Duman N., Yilmaz O., Ozkan H. Maternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brain. J Maternal-Fetal & Neonatal Med 2012, 25:849-854.
223. Uhrmann S., Marks K.H., Maisels M.J., Kulin H.E., Kaplan M., Utiger R. Frequency of transient hypothyroxinaemia in low birthweight infants. Potential pitfall for neonatal screening programmes. Arch Dis Child 1981, 56:214-217.
224. van Meeteren M.E., Baron W., Beermann C., Dijkstra C.D., van Tol E.A. Polyunsaturated fatty acid supplementation stimulates differentiation of oligodendroglia cells. Dev Neurosci 2006, 28:196-208.
225. van Wassenaer A.G., Westera J., Houtzager B.A., Kok J.H. Ten-year follow-up of children born at <30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial. Pediatrics 2005, 116:e613-e618.
226. Vanhole C., Aerssens P., Naulaers G., Casneuf A., Devlieger H., Van den Berghe G., de Zegher F. l-Thyroxine treatment of preterm newborns: clinical and endocrine effects. Pediatr Res 1997, 42:87-92.
227. Vannucci R.C., Vannucci S.J. Perinatal hypoxic-ischemic brain damage: evolution of an animal model. Dev Neurosci 2005, 27:81-86.
228. Verney C., Rees S., Biran V., Thompson M., Inder T., Gressens P. Neuronal damage in the preterm baboon: impact of the mode of ventilatory support. J Neuropathol Exp Neurol 2010, 69:473-482.
229. Vinall J., Grunau R.E., Brant R., Chau V., Poskitt K.J., Synnes A.R., Miller S.P. Slower postnatal growth is associated with delayed cerebral cortical maturation in preterm newborns. Sci Transl Med 2013, 5. 168ra168.
230. Vohr B.R., Poindexter B.B., Dusick A.M., McKinley L.T., Wright L.L., Langer J.C., Poole W.K., Network N.N.R. Beneficial effects of breast milk in the neonatal intensive care unit on the developmental outcome of extremely low birth weight infants at 18 months of age. Pediatrics 2006, 118:e115-e123.
231. Volpe J.J. Anterior fontanel: window to the neonatal brain. J Pediatr 1982, 100:395-398.
232. Volpe J.J. Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 2005, 116:221-225.
233. Volpe J.J. Neurology of the newborn 2008, Saunders, Philadelphia.
234. Volpe J.J. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009, 8:110-124.
235. Volpe J.J., Kinney H.C., Jensen F.E., Rosenberg P.A. The developing oligodendrocyte: key cellular target in brain injury in the premature infant. Int J Dev Neurosci 2011, 29:423-440.
236. Wallen K. Hormonal influences on sexually differentiated behavior in nonhuman primates. Front Neuroendocrinol 2005, 26:7-26.
237. Walters S.N., Morell P. Effects of altered thyroid states on myelinogenesis. J Neurochem 1981, 36:1792-1801.
238. Weiss J., Takizawa B., McGee A., Stewart W.B., Zhang H., Ment L., Schwartz M., Strittmatter S. Neonatal hypoxia suppresses oligodendrocyte Nogo-A and increases axonal sprouting in a rodent model for human prematurity. Exp Neurol 2004, 189:141-149.
239. Westerberg A.C., Schei R., Henriksen C., Smith L., Veierod M.B., Drevon C.A., Iversen P.O. Attention among very low birth weight infants following early supplementation with docosahexaenoic and arachidonic acid. Acta Paediatr 2011, 100:47-52.
240. Wiggins R.C., Fuller G.N. Early postnatal starvation causes lasting brain hypomyelination. J Neurochem 1978, 30:1231-1237.
241. Wiggins R.C., Miller S.L., Benjamins J.A., Krigman M.R., Morell P. Myelin synthesis during postnatal nutritional deprivation and subsequent rehabilitation. Brain Res 1976, 107:257-273.
242. Williams G.R. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol 2008, 20:784-794.
243. Wood T.L., Loladze V., Altieri S., Gangoli N., Levison S.W., Brywe K.G., Mallard C., Hagberg H. Delayed IGF-1 administration rescues oligodendrocyte progenitors from glutamate-induced cell death and hypoxic-ischemic brain damage. Dev Neurosci 2007, 29:302-310.
244. Woodward L.J., Anderson P.J., Austin N.C., Howard K., Inder T.E. Neonatal MRI to predict neurodevelopmental outcomes in preterm infants. N Engl J Med 2006, 355:685-694.
245. Wu Y.W., Escobar G.J., Grether J.K., Croen L.A., Greene J.D., Newman T.B. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003, 290:2677-2684.
246. Ye P., Lee K.H., D'Ercole A.J. Insulin-like growth factor-I (IGF-I) protects myelination from undernutritional insult: studies of transgenic mice overexpressing IGF-I in brain. J Neurosci Res 2000, 62:700-708.
247. Yusta B., Besnard F., Ortiz-Caro J., Pascual A., Aranda A., Sarlieve L. Evidence for the presence of nuclear 3,5,3'-triiodothyronine receptors in secondary cultures of pure rat oligodendrocytes. Endocrinology 1988, 122:2278-2284.
248. Zeger M., Popken G., Zhang J., Xuan S., Lu Q.R., Schwab M.H., Nave K.A., Rowitch D., D'Ercole A.J., Ye P. Insulin-like growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination. Glia 2007, 55:400-411.
249. Zhang S.X., Weilersbacher G.S., Henderson S.W., Corso T., Olney J.W., Langlais P.J. Excitotoxic cytopathology, progression, and reversibility of thiamine deficiency-induced diencephalic lesions. J Neuropathol Exp Neurol 1995, 54:255-267.